Atlas Trials

Oral Amantadine Versus Gabapentin to Attenuate the Response to Laryngoscopy and Tracheal Intubation

Clinical trial NCT03172234 · COMPLETED

Trial details

NCT number
NCT03172234
Sponsor
Ghada Mohammed AboelFadl
Status
COMPLETED
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Effect of Laryngoscopy and Tracheal Intubation
Start date
2017-06-15
Primary completion
2018-05-15
Enrollment
90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.